Correction to “Adjuvant PD‐1 inhibitor versus high‐dose interferon α‐2b for Chinese patients with cutaneous and acral melanoma: A retrospective cohort analysis”

Li J, Wang J, Li D, et al. Adjuvant PD-1 inhibitor versus high-dose interferon α-2b for Chinese patients with cutaneous and acral melanoma: a retrospective cohort analysis. Dermatologic Therapy. 2021;34(5):e15067. Some of the funding information was incorrect. Guangzhou Health and Family Planning Commission Technology Project (20191A1515011263) should have been Guangdong Basic and Applied Basic Research Foundation with the number 2019A1515011263. We apologize for this error. Received: 22 November 2022 Accepted: 22 November 2022